Customers are urged not to use these devices due to a risk of tip separation. The FDA first warned the public about this issue in July.

These findings underscore the importance of making healthy lifestyle decisions at a young age. 

Digital twins may be used in the near future to help clinicians plan ahead before EP ablation procedures. They could preview how the patient's heart will react to treatment, for example, increasing the odds of a positive outcome.

The funding, provided over five years, will go toward developing a robot capable of performing advanced endovascular procedures without direct human input.

Using NT-proBNP testing kits on high-risk patients with diabetes could help get many more patients the care they need, according to new data published in JACC.

A multidisciplinary committee formed in 2022 to identify ways to improve safety and efficiency in their facility's cath lab. By 2024, it was clear the group's proposals had made a major impact.

Ellis Medicine and St. Peter’s Health Partners spent years discussing a merger. After those discussions were abandoned, however, things got ugly between the two New York health systems. The services of 27 cardiologists are at the center of this ongoing dispute.

Implementing advanced AI models into daily practice takes much more than simply installing software. It requires a clinical champion and multiple stakeholders to coordinate the effort.

As always, heart team discussions play a vital role when choosing between TAVR and SAVR for patients with large or extra-large aortic annuli. 

Mohamad Alkhouli, MD, MBA, a professor of medicine at Mayo Clinic School of Medicine and practicing cardiologist, has been named the next editor-in-chief of JACC: Cardiovascular Interventions.

Among the guideline's most significant changes is a Class I recommendation for prophylactic amiodarone.

More than 50,000 devices are being recalled due to pinhole leaks associated with multiple risks. Customers should return any unused cannulae to Medtronic.

Abbott's TriClip system for tricuspid regurgitation is approved by the FDA and covered by Medicare. To learn more about its real-world performance, researchers will now track 1,000 patients for a total of five years. 

The benefits management company Aon said per-employee expenditures may rise about $19,000. While the broader economy is to blame, part of the rise can be attributed to the management of costly chronic conditions such as diabetes. 

Following the criminal sentencing of a morgue manager and his wife in December 2025, the prestigious medical school has agreed to put to rest two class action lawsuits related to the body part selling ring.